Cost Plus Drugs, Humana eye partnership to lower drug costs
Mark Cuban’s Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs...
Patients are blaming insurers for medical debt: survey
U.S. consumers across the political spectrum are largely in favor of new legal protections against medical debt, and the majority...
White paper lays out framework for identifying health disparities
A new evidence-based framework aims to establish a U.S. industry standard for measuring health equity efforts. Put out by the...
CMS drug negotiations boost rheumatological care access
As physicians who treat life-threatening autoimmune disease, we are problem solvers, adept at prescribing diagnostic tests and medications to improve...
$1T healthcare shift is coming, driven by virtual care, AI: PwC
Growing demand for care and a rapidly aging population could drive U.S. healthcare spending to $8.6 trillion by 2035, more...
Prior authorization has created a perception problem
Clear communication, as part of the doctor-patient relationship, is one of the most fundamental aspects of healthcare delivery. Patients need...
Highmark Health net income sinks, down 93% from last year
Elevated medical costs are impacting insurers nationwide, and Highmark Health is no exception, the company shared as it released its...
How higher tariffs could impact health insurers
While health plans are not likely to feel the most acute effects from the Trump administration’s tariffs, they face downhill...
Rural areas rapidly losing independent docs, practices
Rural areas are quickly losing independent physicians and medical practices amid the corporatization of healthcare, a new report finds. The...
Trump’s new tariffs include pharma exemption
Editor’s note: This story has been updated with healthcare industry reactions and additional information released by the administration on the...
